42 results on '"D. Lassner"'
Search Results
2. Individuals with inherited chromosomally integrated human herpes virus 6 (ciHHV-6) have functionally active HHV-6 specific T-cell immunity
- Author
-
Simone Kayser, Wolfgang Schwinger, Christian Urban, Tobias Feuchtinger, Kai-Erik Witte, G. Jahn, Volker Strenger, and D. Lassner
- Subjects
Adult ,Male ,0301 basic medicine ,Microbiology (medical) ,Necrosis ,Herpesvirus 6, Human ,T-Lymphocytes ,Virus Integration ,viruses ,medicine.medical_treatment ,Roseolovirus Infections ,Biology ,medicine.disease_cause ,Immune tolerance ,Flow cytometry ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Chromosomes, Human ,Humans ,Aged ,Aged, 80 and over ,medicine.diagnostic_test ,virus diseases ,Cytomegalovirus ,General Medicine ,Middle Aged ,biochemical phenomena, metabolism, and nutrition ,Acquired immune system ,Virology ,030104 developmental biology ,Infectious Diseases ,Cytokine ,030220 oncology & carcinogenesis ,Immunology ,Cytokines ,Female ,medicine.symptom ,CD8 - Abstract
To evaluate the human herpes virus 6 (HHV-6) -specific immune response in individuals with chromosomally integrated HHV-6 (ciHHV-6), we measured HHV-6-antigen-specific cytokine responses (interferon-γ, interleukin-2, tumour necrosis factor-α) in T cells by flow cytometry in 12 and 16 individuals with and without ciHHV-6, respectively. All individuals with ciHHV-6 showed HHV-6-specific T cells with higher frequencies of HHV-6-specific CD8(+) cells (0.03-14.93, median 2.15% of CD8(+) cells) compared with non-ciHHV-6 (0.0-10.67, median 0.36%, p 0.026). The observed increased HHV-6-specific functionally active responses in individuals with ciHHV-6 clearly disprove speculations on immune tolerance in ciHHV-6 and indicate clinical and immunological implications of ciHHV-6.
- Published
- 2016
3. Using a concept mapping software as a knowledge construction tool in a graduate online course
- Author
-
Basque, Josianne, Pudelko, Béatrice, Laboratoire d'Informatique Cognitive et d'Environnements de Formation - Téluq, l'université à distance de l'UQAM (Centre LICEF - TÉLUQ), Université du Québec à Montréal = University of Québec in Montréal (UQAM), D. Lassner and C. McNaught, and Zeiliger, Jerome
- Subjects
[INFO.EIAH] Computer Science [cs]/Technology for Human Learning ,knowledge constructions ,online course ,[INFO.EIAH]Computer Science [cs]/Technology for Human Learning - Abstract
Used with permission from the Assn. for the Advancement of Computing in Education: www.aace.org; Stemming from a twenty-month pedagogical experience using a concept mapping software for higher education students in an online course, this paper reports findings from what became an exploratory study. The objectives were to support the students' knowledge construction process and to stimulate metacognitive reflection. After having read some instructional texts, students used an object-oriented modeling tool called MOT) to graphically represent a network of at least fifteen knowledge units of their choice. They also had to “explain” their concept map in a narrative format. Based on questionnaire data, comments expressed spontaneously by students in the online forums, and the analysis of their concept maps, the following themes are discussed: (1) students' attitudes toward concept mapping, (2) how they executed the concept mapping task, and (3) characteristics of the maps produced. In conclusion, some research issues are outlined.
- Published
- 2003
4. Evolutionary History of Endogenous Human Herpesvirus 6 Reflects Human Migration out of Africa.
- Author
-
Aswad A, Aimola G, Wight D, Roychoudhury P, Zimmermann C, Hill J, Lassner D, Xie H, Huang ML, Parrish NF, Schultheiss HP, Venturini C, Lager S, Smith GCS, Charnock-Jones DS, Breuer J, Greninger AL, and Kaufer BB
- Subjects
- Africa, Humans, Phylogeography, Herpesvirus 6, Human genetics, Human Migration, Phylogeny
- Abstract
Human herpesvirus 6A and 6B (HHV-6) can integrate into the germline, and as a result, ∼70 million people harbor the genome of one of these viruses in every cell of their body. Until now, it has been largely unknown if 1) these integrations are ancient, 2) if they still occur, and 3) whether circulating virus strains differ from integrated ones. Here, we used next-generation sequencing and mining of public human genome data sets to generate the largest and most diverse collection of circulating and integrated HHV-6 genomes studied to date. In genomes of geographically dispersed, only distantly related people, we identified clades of integrated viruses that originated from a single ancestral event, confirming this with fluorescent in situ hybridization to directly observe the integration locus. In contrast to HHV-6B, circulating and integrated HHV-6A sequences form distinct clades, arguing against ongoing integration of circulating HHV-6A or "reactivation" of integrated HHV-6A. Taken together, our study provides the first comprehensive picture of the evolution of HHV-6, and reveals that integration of heritable HHV-6 has occurred since the time of, if not before, human migrations out of Africa., (© The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Molecular Biology and Evolution.)
- Published
- 2021
- Full Text
- View/download PDF
5. Detection of parvovirus mRNAs as markers for viral activity in endomyocardial biopsy-based diagnosis of patients with unexplained heart failure.
- Author
-
Pietsch H, Escher F, Aleshcheva G, Lassner D, Bock CT, and Schultheiss HP
- Subjects
- Adult, Biopsy, Female, Heart physiopathology, Heart virology, Heart Failure complications, Heart Failure genetics, Heart Failure virology, Humans, Male, Middle Aged, Parvovirus B19, Human genetics, Parvovirus B19, Human pathogenicity, RNA, Messenger genetics, RNA, Messenger isolation & purification, Somatoform Disorders complications, Somatoform Disorders genetics, Somatoform Disorders virology, Viral Proteins genetics, Viral Proteins isolation & purification, Virus Diseases complications, Virus Diseases virology, Heart Failure diagnosis, Parvovirus B19, Human isolation & purification, Somatoform Disorders diagnosis, Virus Diseases genetics
- Abstract
Erythroparvovirus (B19V) genomes have been detected in various organs of infected individuals including endothelial cells of the heart muscle. However, the role of B19V as a causative pathogen of myocardial damage is still unknown. The majority of reports focus on the presence of viral DNA ignoring proof of viral RNAs as important markers for viral activity. During this study, we established (RT-) qPCR to characterize expression of B19V RNAs (NS1 and VP1/2) in endomyocardial biopsies (EMBs) of 576 patients with unexplained heart failure. 403/576 (70%) EMBs were positive for B19V DNA. B19V mRNAs NS1 and/or VP1/2, indicating viral activity, could be detected in 38.5% of B19V DNA positive samples using the newly established B19V RT-PCRs. 22.1% of samples were characterized by only NS1 mRNA detection while 6.0% revealed only VP1/2 mRNA expression. Detection of both intermediates was successful in 10.4% of samples. Applying the molecular testing, our study revealed that a high proportion (38.5%) of B19V DNA positive EMBs was characterized by viral transcriptional activity. Further prospective studies will evaluate relevance of viral transcription intermediates as a diagnostic marker to differentiate between latent B19V infection and clinically relevant transcriptionally active B19V-infection of the heart muscle.
- Published
- 2020
- Full Text
- View/download PDF
6. Development of a new mouse model for coxsackievirus-induced myocarditis by attenuating coxsackievirus B3 virulence in the pancreas.
- Author
-
Pinkert S, Pryshliak M, Pappritz K, Knoch K, Hazini A, Dieringer B, Schaar K, Dong F, Hinze L, Lin J, Lassner D, Klopfleisch R, Solimena M, Tschöpe C, Kaya Z, El-Shafeey M, Beling A, Kurreck J, Van Linthout S, Klingel K, and Fechner H
- Subjects
- 3' Untranslated Regions, Animals, Coxsackievirus Infections metabolism, Coxsackievirus Infections pathology, Disease Models, Animal, Enterovirus B, Human genetics, Female, Fibrosis, Genotype, HEK293 Cells, HeLa Cells, Humans, Mice, Inbred BALB C, Mice, Inbred C57BL, MicroRNAs genetics, Myocarditis metabolism, Myocarditis pathology, Myocytes, Cardiac metabolism, Myocytes, Cardiac pathology, Pancreatitis prevention & control, Phenotype, Virulence, Virus Replication, Coxsackievirus Infections virology, Enterovirus B, Human pathogenicity, Myocarditis virology, Myocytes, Cardiac virology, Pancreas virology, Pancreatitis virology
- Abstract
Aims: The coxsackievirus B3 (CVB3) mouse myocarditis model is the standard model for investigation of virus-induced myocarditis but the pancreas, rather than the heart, is the most susceptible organ in mouse. The aim of this study was to develop a CVB3 mouse myocarditis model in which animals develop myocarditis while attenuating viral infection of the pancreas and the development of severe pancreatitis., Methods and Results: We developed the recombinant CVB3 variant H3N-375TS by inserting target sites (TS) of miR-375, which is specifically expressed in the pancreas, into the 3'UTR of the genome of the pancreo- and cardiotropic CVB3 variant H3. In vitro evaluation showed that H3N-375TS was suppressed in pancreatic miR-375-expressing EndoC-βH1 cells >5 log10, whereas its replication was not suppressed in isolated primary embryonic mouse cardiomyocytes. In vivo, intraperitoneal (i.p.) administration of H3N-375TS to NMRI mice did not result in pancreatic or cardiac infection. In contrast, intravenous (i.v.) administration of H3N-375TS to NMRI and Balb/C mice resulted in myocardial infection and acute and chronic myocarditis, whereas the virus was not detected in the pancreas and the pancreatic tissue was not damaged. Acute myocarditis was characterized by myocardial injury, inflammation with mononuclear cells, induction of proinflammatory cytokines, and detection of replicating H3N-375TS in the heart. Mice with chronic myocarditis showed myocardial fibrosis and persistence of H3N-375TS genomic RNA but no replicating virus in the heart. Moreover, H3N-375TS infected mice showed distinctly less suffering compared with mice that developed pancreatitis and myocarditis after i.p. or i.v application of control virus., Conclusion: In this study, we demonstrate that by use of the miR-375-sensitive CVB3 variant H3N-375TS, CVB3 myocarditis can be established without the animals developing severe systemic infection and pancreatitis. As the H3N-375TS myocarditis model depends on pancreas-attenuated H3N-375TS, it can easily be used in different mouse strains and for various applications., (Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.)
- Published
- 2020
- Full Text
- View/download PDF
7. Protease-activated receptor 2 deficiency mediates cardiac fibrosis and diastolic dysfunction.
- Author
-
Friebel J, Weithauser A, Witkowski M, Rauch BH, Savvatis K, Dörner A, Tabaraie T, Kasner M, Moos V, Bösel D, Gotthardt M, Radke MH, Wegner M, Bobbert P, Lassner D, Tschöpe C, Schutheiss HP, Felix SB, Landmesser U, and Rauch U
- Subjects
- Aged, Animals, Cardiomyopathies pathology, Female, Fibrosis pathology, Heart Failure, Diastolic metabolism, Humans, Male, Mice, Mice, Knockout, Middle Aged, Myocardium pathology, Transforming Growth Factor beta metabolism, Cardiomyopathies metabolism, Fibrosis metabolism, Myocardium metabolism, Receptor, PAR-2 deficiency, Receptor, PAR-2 genetics, Receptor, PAR-2 metabolism
- Abstract
Aims: Heart failure with preserved ejection fraction (HFpEF) and pathological cardiac aging share a complex pathophysiology, including extracellular matrix remodelling (EMR). Protease-activated receptor 2 (PAR2) deficiency is associated with EMR. The roles of PAR1 and PAR2 have not been studied in HFpEF, age-dependent cardiac fibrosis, or diastolic dysfunction (DD)., Methods and Results: Evaluation of endomyocardial biopsies from patients with HFpEF (n = 14) revealed that a reduced cardiac PAR2 expression was associated with aggravated DD and increased myocardial fibrosis (r = -0.7336, P = 0.0028). In line, 1-year-old PAR2-knockout (PAR2ko) mice suffered from DD with preserved systolic function, associated with an increased age-dependent α-smooth muscle actin expression, collagen deposition (1.7-fold increase, P = 0.0003), lysyl oxidase activity, collagen cross-linking (2.2-fold increase, P = 0.0008), endothelial activation, and inflammation. In the absence of PAR2, the receptor-regulating protein caveolin-1 was down-regulated, contributing to an augmented profibrotic PAR1 and transforming growth factor beta (TGF-β)-dependent signalling. This enhanced TGF-β/PAR1 signalling caused N-proteinase (ADAMTS3) and C-proteinase (BMP1)-related increased collagen I production from cardiac fibroblasts (CFs). PAR2 overexpression in PAR2ko CFs reversed these effects. The treatment with the PAR1 antagonist, vorapaxar, reduced cardiac fibrosis by 44% (P = 0.03) and reduced inflammation in a metabolic disease model (apolipoprotein E-ko mice). Patients with HFpEF with upstream PAR inhibition via FXa inhibitors (n = 40) also exhibited reduced circulating markers of fibrosis and DD compared with patients treated with vitamin K antagonists (n = 20)., Conclusions: Protease-activated receptor 2 is an important regulator of profibrotic PAR1 and TGF-β signalling in the heart. Modulation of the FXa/FIIa-PAR1/PAR2/TGF-β-axis might be a promising therapeutic approach to reduce HFpEF., (Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.)
- Published
- 2019
- Full Text
- View/download PDF
8. Disconnect between Fibrotic Response and Right Ventricular Dysfunction.
- Author
-
Crnkovic S, Egemnazarov B, Damico R, Marsh LM, Nagy BM, Douschan P, Atsina K, Kolb TM, Mathai SC, Hooper JE, Ghanim B, Klepetko W, Fruhwald F, Lassner D, Olschewski A, Olschewski H, Hassoun PM, and Kwapiszewska G
- Subjects
- Animals, Austria, Baltimore, Disease Models, Animal, Humans, Male, Mice, Rats, Ventricular Function, Right drug effects, Fibrosis complications, Fibrosis physiopathology, Galectin 3 immunology, Hypertrophy, Right Ventricular etiology, Hypertrophy, Right Ventricular physiopathology, Ventricular Dysfunction, Right etiology, Ventricular Dysfunction, Right physiopathology
- Abstract
Rationale: Remodeling and fibrosis of the right ventricle (RV) may cause RV dysfunction and poor survival in patients with pulmonary hypertension. Objectives: To investigate the consequences of RV fibrosis modulation and the accompanying cellular changes on RV function. Methods: Expression of fibrotic markers was assessed in the RV of patients with pulmonary hypertension, the murine pulmonary artery banding, and rat monocrotaline and Sugen5416/hypoxia models. Invasive hemodynamic and echocardiographic assessment was performed on galectin-3 knockout or inhibitor-treated mice. Measurements and Main Results: Established fibrosis was characterized by marked expression of galectin-3 and an enhanced number of proliferating RV fibroblasts. Galectin-3 genetic and pharmacologic inhibition or antifibrotic treatment with pirfenidone significantly diminished RV fibrosis progression in the pulmonary artery banding model, without improving RV functional parameters. RV fibrotic regions were populated with mesenchymal cells coexpressing vimentin and PDGFRα (platelet-derived growth factor receptor-α), but generally lacked αSMA (α-smooth muscle actin) positivity. Serum levels of galectin-3 were increased in patients with idiopathic pulmonary arterial hypertension but did not correlate with cardiac function. No changes of galectin-3 expression were observed in the lungs. Conclusions: We identified extrapulmonary galectin-3 as an important mediator that drives RV fibrosis in pulmonary hypertension through the expansion of PDGFRα/vimentin-expressing cardiac fibroblasts. However, interventions effectively targeting fibrosis lack significant beneficial effects on RV function.
- Published
- 2019
- Full Text
- View/download PDF
9. Telbivudine Reduces Parvovirus B19-Induced Apoptosis in Circulating Angiogenic Cells.
- Author
-
Zobel T, Bock CT, Kühl U, Rohde M, Lassner D, Schultheiss HP, and Schmidt-Lucke C
- Subjects
- Angiogenic Proteins genetics, Baculoviral IAP Repeat-Containing 3 Protein genetics, Caspase 3 genetics, Cell Line, DNA, Viral metabolism, Endothelial Cells drug effects, Endothelial Cells virology, Humans, Parvovirus B19, Human physiology, Receptors, CXCR4 genetics, Virus Replication drug effects, Antiviral Agents pharmacology, Apoptosis, Parvovirus B19, Human drug effects, Signal Transduction, Telbivudine pharmacology
- Abstract
Aims: Human parvovirus B19 (B19V) infection directly induces apoptosis and modulates CXCR4 expression of infected marrow-derived circulating angiogenic cells (CACs). This leads to dysfunctional endogenous vascular repair. Treatment for B19V-associated disease is restricted to symptomatic treatment. Telbivudine, a thymidine analogue, established in antiviral treatment for chronic hepatitis B, modulates pathways that might influence induction of apoptosis. Therefore, we tested the hypothesis of whether telbivudine influences B19V-induced apoptosis of CAC. Methods and Results: Pretreatment of two CAC-lines, early outgrowth endothelial progenitor cells (eo-EPC) and endothelial colony-forming cells (ECFC) with telbivudine before in vitro infection with B19V significantly reduced active caspase-3 protein expression (-39% and -40%, both p < 0.005). Expression of Baculoviral Inhibitor of apoptosis Repeat-Containing protein 3 (BIRC3) was significantly downregulated by in vitro B19V infection in ECFC measured by qRT-PCR. BIRC3 downregulation was abrogated with telbivudine pretreatment ( p < 0.001). This was confirmed by single gene PCR ( p = 0.017) and Western blot analysis. In contrast, the missing effect of B19V on angiogenic gene expression postulates a post-transcriptional modulation of CXCR4. Conclusions: We for the first time show a treatment approach to reduce B19V-induced apoptosis. Telbivudine reverses B19V-induced dysregulation of BIRC3, thus, intervening in the apoptosis pathway and protecting susceptible cells from cell death. This approach could lead to an effective B19V treatment to reduce B19V-related disease.
- Published
- 2019
- Full Text
- View/download PDF
10. High-resolution respirometry in human endomyocardial biopsies shows reduced ventricular oxidative capacity related to heart failure.
- Author
-
Scheiber D, Jelenik T, Zweck E, Horn P, Schultheiss HP, Lassner D, Boeken U, Saeed D, Kelm M, Roden M, Westenfeld R, and Szendroedi J
- Subjects
- Aged, Biomarkers, Biopsy, Cell Respiration, Comorbidity, Gene Expression, Heart Failure pathology, Heart Failure physiopathology, Heart Ventricles pathology, Heart Ventricles physiopathology, Humans, Hydrogen Peroxide metabolism, Middle Aged, Mitochondria, Heart metabolism, Myocardium pathology, Oxidation-Reduction, Heart Failure genetics, Heart Failure metabolism, Heart Ventricles metabolism, Myocardium metabolism, Oxidative Stress
- Abstract
The lifetime risk of developing heart failure is approximately 20%, and survival rates remain poor. Myocardial mitochondrial function has been suggested to play a pivotal role in heart failure pathophysiology. Human studies on ex vivo mitochondrial function have mostly been limited to atrial tissue obtained during open heart surgery and have provided contradictory results. This study aimed at measuring myocardial mitochondrial function in transcatheter ventricular endomyocardial biopsies and assessing the relationship between oxidative capacity and heart function. We enrolled 40 heart failure patients undergoing ventricular assist device surgery or heart transplantation (34 males, age 57 ± 11 years, body mass index 26.6 ± 4.8 kg/m
2 ) and 29 heart transplant recipients of comparable age and body mass index with normal left ventricular function undergoing surveillance biopsies (23 males, 57 ± 12 years, body mass index 26.2 ± 4.1 kg/m2 ). High-resolution respirometry was established in the myocardium to measure oxidative capacity ex vivo. The mitochondrial oxidative capacity was 90% higher in ventricular compared to atrial tissues (n = 11, p < 0.01) of explanted hearts. Respiration rates were comparable in ventricular samples of heart failure patients obtained during open heart surgery by standard tissue preparation or ex vivo endomyocardial biopsy (r = 0.9988, p < 0.0001, n = 8), and the mitochondrial oxidative capacity in samples from these patients remained stable for 8 h when stored in either of two common preservation buffers. The oxidative capacity was 44% lower in heart failure than in transplant recipients (67 ± 3 vs. 97 ± 5 pmol/[s mg], p < 0.0001) and correlated positively with heart function (r = 0.49, p < 0.01). High-resolution respirometry of ventricular tissue is feasible in transcatheter biopsies, facilitating clinical studies on myocardial mitochondrial function in patients not undergoing heart surgery.- Published
- 2019
- Full Text
- View/download PDF
11. Telbivudine in chronic lymphocytic myocarditis and human parvovirus B19 transcriptional activity.
- Author
-
Van Linthout S, Elsanhoury A, Klein O, Sosnowski M, Miteva K, Lassner D, Abou-El-Enein M, Pieske B, Kühl U, and Tschöpe C
- Subjects
- Antiviral Agents therapeutic use, Apoptosis, Cell Line, Chronic Disease, Endothelium, Vascular drug effects, Endothelium, Vascular pathology, Endothelium, Vascular virology, Female, Flow Cytometry, Humans, Lymphocytes virology, Male, Middle Aged, Myocarditis pathology, Myocarditis virology, Myocardium metabolism, DNA, Viral analysis, Heart Ventricles diagnostic imaging, Lymphocytes pathology, Myocarditis drug therapy, Myocardium pathology, Parvovirus B19, Human genetics, Telbivudine therapeutic use
- Abstract
Aims: Myocarditis is often associated with parvovirus B19 (B19V) persistence, which can induce vascular damage. Based on the antiviral and anti-inflammatory properties of telbivudine, we aimed to evaluate its efficacy to protect B19V-infected endothelial cells in vitro and to treat chronic lymphocytic myocarditis patients with B19V transcriptional activity., Methods and Results: We evaluated the endothelial-protective potential of telbivudine in human microvascular endothelial cells-1, which were infected with B19V. Treatment with 10 ng/mL of telbivudine decreased the B19V-induced endothelial cell apoptosis and endothelial-to-mesenchymal transition. Along with this finding, telbivudine reduced the expression of transforming growth factor-β1 and of tenascin-C. The endothelial-protective properties of telbivudine were also found in tumour necrosis factor-α-stressed human microvascular endothelial cells-1. In addition, oxidative stress in angiotensin II-stressed and transforming growth factor-β1-stressed HL-1 cardiomyocytes and fibroblasts, respectively, was reduced upon telbivudine treatment, illustrating that telbivudine exerts multimodal protective effects. Based on these in vitro findings, four patients severely suffering from an endomyocardial biopsy-proven myocarditis associated with B19V transcriptional activity (VP1/VP2-mRNA positive) were treated with telbivudine (600 mg/dL) for 6 months in a single-patient-use approach. Follow-up biopsies 6 months after treatment showed that VP1/VP2-mRNA levels and CD3 cells decreased in all patients and were associated with an improvement in ejection fraction and New York Heart Association class. These findings were paralleled by a drop in tenascin-C expression as shown via matrix-assisted laser desorption ionization-imaging mass spectrometry., Conclusions: Telbivudine exerts endothelial-protective effects in B19V-infected endothelial cells and improves chronic myocarditis associated with B19V transcriptional activity. These findings will be further evaluated in the clinical exploratory trial: the PreTopic study., (© 2018 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology.)
- Published
- 2018
- Full Text
- View/download PDF
12. CCR5del32 genotype in human enteroviral cardiomyopathy leads to spontaneous virus clearance and improved outcome compared to wildtype CCR5.
- Author
-
Lassner D, Siegismund CS, Kühl U, Rohde M, Stroux A, Escher F, and Schultheiss HP
- Subjects
- Adult, Aged, Antigen-Presenting Cells, Antiviral Agents therapeutic use, Biopsy, Cytokines blood, Female, Genotype, Humans, Immunologic Memory, Inflammation, Interferon-beta metabolism, Kaplan-Meier Estimate, Killer Cells, Natural cytology, Male, Middle Aged, Mutation, Phenotype, Polymorphism, Genetic, Prognosis, Retrospective Studies, T-Lymphocytes immunology, Treatment Outcome, Cardiomyopathies genetics, Cardiomyopathies virology, Enterovirus, Enterovirus Infections genetics, Receptors, CCR5 genetics
- Abstract
Background: Enteroviral cardiomyopathy is a life-threatening disease, and detection of enterovirus (EV) RNA in the initial endomyocardial biopsy is associated with adverse prognosis and increased mortality. Some patients with EV infection may spontaneously eliminate the virus and recover, whereas those with virus persistence deteriorate and progress to heart failure. Interferon-beta (IFN-β) therapy eliminates the virus, resulting in increased survival of treated patients. CCR5 is expressed on antigen-presenting cells (both macrophages and dendritic cells) and immune effector cells (T-lymphocytes with memory/effector phenotype and natural killer cells). Its 32-bp deletion (CCR5del32) is the most frequent human coding sequence mutation. This study addresses the correlation of CCR5 polymorphism to the clinical course of EV infection and the necessity for IFN-β treatment., Methods: We examined 97 consecutive patients with chronic/inflammatory cardiomyopathy and biopsy-proven EV infection and reliable information on clinical outcomes by CCr5 genotyping. These data were evaluated in relation to virus persistence in follow-up biopsies and survival rates over a 15-year period., Results: Genotyping revealed a strong correlation between the CCR5del32 genotype and spontaneous virus clearance with improved outcomes. All patients with CCR5del32 eliminated EV spontaneously and none of them died within the observed period. In the group of untreated CCR5 wildtype patients, 33% died (Kaplan-Meier log-rank p = 0.010). However, CCR5 wildtype individuals treated with IFN-β are more likely to survive than without therapy (Kaplan-Meier log-rank p = 0.004) in identical proportions to individuals with the CCR5del32 genotype., Conclusions: These data suggest that CCR5 genotyping is a novel predictive genetic marker for the clinical course of human EV cardiomyopathies. Hereby clinicians can identify those EV positive individuals who will eliminate the virus spontaneously based on CCR5 phenotype and those patients with CCR5 wildtype genotype who would be eligible for immediate antiviral IFN-β treatment to minimize irreversible cardiac damage.
- Published
- 2018
- Full Text
- View/download PDF
13. Intramyocardial inflammation predicts adverse outcome in patients with cardiac AL amyloidosis.
- Author
-
Siegismund CS, Escher F, Lassner D, Kühl U, Gross U, Fruhwald F, Wenzel P, Münzel T, Frey N, Linke RP, and Schultheiss HP
- Subjects
- Aged, Amyloid metabolism, Amyloidosis metabolism, Biopsy, Cardiomyopathies metabolism, Female, Humans, Inflammation metabolism, Male, Middle Aged, Myocardium metabolism, Prealbumin metabolism, Prognosis, Amyloidosis diagnosis, Cardiomyopathies diagnosis, Inflammation pathology, Myocardium pathology
- Abstract
Aims: To evaluate the influence of endomyocardial biopsy (EMB)-proven intramyocardial inflammation on mortality in patients with cardiac transthyretin amyloid (ATTR) or amyloid light-chain (AL) amyloidosis., Methods and Results: We included 54 consecutive patients (mean age 68.83 ± 9.59 years; 45 men) with EMB-proven cardiac amyloidosis. We followed up patients from first diagnostic biopsy to as long as 36 months (mean 11.5 ± 12 months) and compared their outcome with information on all-cause mortality with or without proof of inflammation on EMB. Intramyocardial inflammation was assessed by quantitative immunohistology. Patients suffering from amyloidosis revealed a significant poor prognosis with proof of intramyocardial inflammation in contrast to those without inflammation (log-rank P = 0.019). Re-grouping of patients indicated AL amyloidosis to have a significant impact on all-cause mortality (log-rank P = 0.012). The detailed subgroup analysis showed that patients suffering from AL amyloidosis with intramyocardial inflammation have a significantly worse prognosis compared with AL amyloidosis without inflammation and ATTR with or without inflammation, respectively (log-rank P = 0.014, contingency Fisher's exact test, P = 0.008)., Conclusion: Our study reports for the first time a high incidence (48.1%) of intramyocardial inflammation in a series of patients with EMB-proven cardiac amyloidosis and could show that in patients with AL amyloidosis, intramyocardial inflammation correlated significantly with increased mortality. Our data have a direct clinical impact because one can hypothesize that additional immunomodulating/anti-inflammatory treatment regimens in patients with biopsy-proven inflammation of heart muscle tissue could be beneficial for patients suffering from cardiac AL amyloidosis., (© 2017 The Authors. European Journal of Heart Failure © 2017 European Society of Cardiology.)
- Published
- 2018
- Full Text
- View/download PDF
14. The forkhead transcription factor Foxo3 negatively regulates natural killer cell function and viral clearance in myocarditis.
- Author
-
Loebel M, Holzhauser L, Hartwig JA, Shukla PC, Savvatis K, Jenke A, Gast M, Escher F, Becker SC, Bauer S, Stroux A, Beling A, Kespohl M, Pinkert S, Fechner H, Kuehl U, Lassner D, Poller W, Schultheiss HP, Zeller T, Blankenberg S, Papageorgiou AP, Heymans S, Landmesser U, Scheibenbogen C, and Skurk C
- Subjects
- Adult, Animals, Coxsackievirus Infections immunology, Coxsackievirus Infections virology, Cytokines metabolism, Disease Models, Animal, Female, Heart virology, Humans, Male, Mice, Mice, Knockout, Middle Aged, Myocardium immunology, Myocardium pathology, Polymorphism, Single Nucleotide, Forkhead Box Protein O3 genetics, Forkhead Box Protein O3 immunology, Forkhead Box Protein O3 metabolism, Killer Cells, Natural immunology, Myocarditis immunology, Myocarditis pathology, Myocarditis virology
- Abstract
Aims: Foxo3 is a transcription factor involved in cell metabolism, survival, and inflammatory disease. However, mechanistic insight in Foxo3 effects is still limited. Here, we investigated the role of Foxo3 on natural killer (NK) cell responses and its effects in viral myocarditis., Methods and Results: Effects of Foxo3 on viral load and immune responses were investigated in a model of coxsackie virus B3 myocarditis in wild-type (WT) and Foxo3 deficient mice. Reduced immune cell infiltration, viral titres, and pro-inflammatory cytokines in cardiac tissue were observed in Foxo3-/- mice 7 days post-infection (p.i.). Viral titres were also attenuated in hearts of Foxo3-/- mice at Day 3 while interferon-γ (IFNγ) and NKp46 expression were up-regulated suggesting early viral control by enhanced NK cell activity. CD69 expression of NK cells, frequencies of CD11b+CD27+ effector NK cells and cytotoxicity of Foxo3-/- mice was enhanced compared to WT littermates. Moreover, microRNA-155 expression, essential in NK cell activation, was elevated in Foxo3-/- NK cells while its inhibition led to diminished IFNγ production. Healthy humans carrying the longevity-associated FOXO3 single nucleotide polymorphism (SNP) rs12212067 exhibited reduced IFNγ and cytotoxic degranulation of NK cells. Viral inflammatory cardiomyopathy (viral CMI) patients with this SNP showed a poorer outcome due to less efficient virus control., Conclusion: Our results implicate Foxo3 in regulating NK cell function and suggest Foxo3 playing an important role in the antiviral innate immunity. Thus, enhanced FOXO3 activity such as in the polymorphism rs12212067 may be protective in chronic inflammation such as cancer and cardiovascular disease but disadvantageous to control acute viral infection.
- Published
- 2018
- Full Text
- View/download PDF
15. Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3-Induced Myocarditis.
- Author
-
Müller I, Vogl T, Pappritz K, Miteva K, Savvatis K, Rohde D, Most P, Lassner D, Pieske B, Kühl U, Van Linthout S, and Tschöpe C
- Subjects
- Adult, Animals, Calgranulin A deficiency, Calgranulin A genetics, Calgranulin B genetics, Case-Control Studies, Chemokine CXCL2 metabolism, Coxsackievirus Infections diagnosis, Coxsackievirus Infections genetics, Coxsackievirus Infections virology, Disease Models, Animal, Enterovirus B, Human genetics, Female, Fibrosis, Host-Pathogen Interactions, Humans, Macrophages metabolism, Macrophages virology, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Middle Aged, Myocarditis diagnosis, Myocarditis genetics, Myocarditis virology, Myocytes, Cardiac pathology, Myocytes, Cardiac virology, Neutrophil Infiltration, Oxidative Stress, RAW 264.7 Cells, RNA Interference, RNA, Messenger genetics, Receptor for Advanced Glycation End Products metabolism, Signal Transduction, Transfection, Ventricular Function, Left, Calgranulin A metabolism, Calgranulin B metabolism, Coxsackievirus Infections metabolism, Enterovirus B, Human pathogenicity, Myocarditis metabolism, Myocytes, Cardiac metabolism
- Abstract
Background: The alarmins S100A8 and S100A9 are damage-associated molecular patterns, which play a pivotal role in cardiovascular diseases, inflammation, and viral infections. We aimed to investigate their role in Coxsackievirus B3 (CVB3)-induced myocarditis., Methods and Results: S100A8 and S100A9 mRNA expression was 13.0-fold ( P =0.012) and 5.1-fold ( P =0.038) higher in endomyocardial biopsies from patients with CVB3-positive myocarditis compared with controls, respectively. Elimination of CVB3 led to a downregulation of these alarmins. CVB3-infected mice developed an impaired left ventricular function and displayed an increased left ventricular S100A8 and S100A9 protein expression versus controls. In contrast, CVB3-infected S100A9 knockout mice, which are also a complete knockout for S100A8 on protein level, showed an improved left ventricular function, which was associated with a reduced cardiac inflammatory and oxidative response, and lower CVB3 copy number compared with wild-type CVB3 mice. Exogenous application of S100A8 to S100A9 knockout CVB3 mice induced a severe myocarditis similar to wild-type CVB3 mice. In CVB3-infected HL-1 cells, S100A8 and S100A9 enhanced oxidative stress and CVB3 copy number compared with unstimulated infected cells. In CVB3-infected RAW macrophages, both alarmins increased MIP-2 (macrophage inflammatory protein-2) chemokine expression, which was reduced in CVB3 S100A8 knockdown versus scrambled siRNA CVB3 cells., Conclusions: S100A8 and S100A9 aggravate CVB3-induced myocarditis and might serve as therapeutic targets in inflammatory cardiomyopathies., (© 2017 American Heart Association, Inc.)
- Published
- 2017
- Full Text
- View/download PDF
16. NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis.
- Author
-
Tschöpe C, Müller I, Xia Y, Savvatis K, Pappritz K, Pinkert S, Lassner D, Heimesaat MM, Spillmann F, Miteva K, Bereswill S, Schultheiss HP, Fechner H, Pieske B, Kühl U, and Van Linthout S
- Subjects
- Animals, Apoptosis, Apoptosis Regulatory Proteins metabolism, CARD Signaling Adaptor Proteins, Case-Control Studies, Caspase 1 metabolism, Cell Line, Coxsackievirus Infections immunology, Coxsackievirus Infections prevention & control, Coxsackievirus Infections virology, Disease Models, Animal, Enterovirus B, Human genetics, Enterovirus B, Human immunology, Genetic Predisposition to Disease, Host-Pathogen Interactions, Humans, Interleukin-1beta metabolism, Male, Mice, Inbred C57BL, Mice, Knockout, Myocarditis immunology, Myocarditis prevention & control, Myocarditis virology, Myocardium immunology, Myocardium pathology, NLR Family, Pyrin Domain-Containing 3 Protein metabolism, Nod2 Signaling Adaptor Protein deficiency, Nod2 Signaling Adaptor Protein genetics, Phenotype, RNA Interference, Signal Transduction, Transfection, Up-Regulation, Coxsackievirus Infections metabolism, Enterovirus B, Human metabolism, Myocarditis metabolism, Myocardium metabolism, Nod2 Signaling Adaptor Protein metabolism
- Abstract
Background: The cytoplasmatic pattern recognition receptor, NOD2 (nucleotide-binding oligomerization domain 2), belongs to the innate immune system and is among others responsible for the recognition of single-stranded RNA. With Coxsackievirus B3 (CVB3) being a single-stranded RNA virus, and the recent evidence that the NOD2 target, NLRP3 (NOD-like receptor family, pyrin domain containing 3) is of importance in the pathogenesis of CVB3-induced myocarditis, we aimed to unravel the role of NOD2 in CVB3-induced myocarditis., Methods and Results: Endomyocardial biopsy NOD2 mRNA expression was higher in CVB3-positive patients compared with patients with myocarditis but without evidence of persistent CVB3 infection. Left ventricular NOD2 mRNA expression was also induced in CVB3-induced myocarditis versus healthy control mice. NOD2 knockdown
(-/- ) mice were rescued from the detrimental CVB3-mediated effects as shown by a reduced cardiac inflammation (less cardiac infiltrates and suppression of proinflammatory cytokines), cardiac fibrosis, apoptosis, lower CAR (Coxsackievirus and adenovirus receptor) expression and CVB3 copy number, and an improved left ventricular function in NOD2-/- CVB3 mice compared with wild-type CVB3 mice. In agreement, NOD2-/- decreased the CVB3-induced inflammatory response, CVB3 copy number, and apoptosis in vitro. NOD2-/- was further associated with a reduction in CVB3-induced NLRP3 expression and activity as evidenced by lower ASC (apoptosis-associated speck-like protein containing a CARD) expression, caspase 1 activity, or IL-1β (interleukin-1β) protein expression under in vivo and in vitro CVB3 conditions., Conclusions: NOD2 is an important mediator in the viral uptake and inflammatory response during the pathogenesis of CVB3 myocarditis., (© 2017 American Heart Association, Inc.)- Published
- 2017
- Full Text
- View/download PDF
17. High Perforin-Positive Cardiac Cell Infiltration and Male Sex Predict Adverse Long-Term Mortality in Patients With Inflammatory Cardiomyopathy.
- Author
-
Escher F, Kühl U, Lassner D, Stroux A, Gross U, Westermann D, Pieske B, Poller W, and Schultheiss HP
- Subjects
- Adult, Aged, Biomarkers analysis, Biopsy, Cardiomyopathies metabolism, Cardiomyopathies pathology, Cardiomyopathies physiopathology, Female, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Multivariate Analysis, Myocarditis metabolism, Myocarditis pathology, Myocarditis physiopathology, Myocardium immunology, Myocardium pathology, Prognosis, Proportional Hazards Models, Risk Factors, Sex Factors, Stroke Volume, Time Factors, Up-Regulation, Ventricular Function, Left, Cardiomyopathies mortality, Chemotaxis, Leukocyte, Myocarditis mortality, Myocardium chemistry, Perforin analysis
- Abstract
Background: The authors analyzed the effects of perforin-dependent infiltration on long-term mortality in patients with inflammatory cardiomyopathy (CMi). We previously demonstrated that left ventricular function deteriorates and progresses to substantial cardiac dysfunction in patients with perforin-positive cardiac cell infiltration., Methods and Results: Between 2003 and 2013, 2389 consecutive patients with clinically suspected CMi who underwent endomyocardial biopsies were enrolled. Endomyocardial biopsies were performed at first admission after exclusion of ischemic or valvular heart disease, and CMi was confirmed in 1717 patients. Follow-up was up to 10.1 years (median 0.47 years; interquartile range, 0.03-2.56 years) and information on vital status was obtained from official resident data files. Multivariable statistical analysis was conducted for all patients with CMi regarding significant predictors of all-cause mortality or need for heart transplantation. Multiple Cox regression analysis revealed perforin above the calculated cutoff point of 2.9 cells/mm² as a strong predictor of impaired survival with a hazard ratio of 1.881 (95% confidence interval, 1.177-3.008; P =0.008), independent of left ventricular function and other myocardial inflammation markers (CD3, macrophage-1 antigen, leukocyte function-associated antigen-1, human leukocyte antigen-1, and intercellular cell adhesion molecule-1). Unexpectedly, male sex emerged as another strong adverse predictor of survival in CMi (hazard ratio, 1.863; confidence interval, 1.096-3.168 [ P =0.022]). Whereas left ventricular ejection fraction course is adversely affected by myocardial perforin, multivariate analysis indicates that left ventricular ejection fraction explains only part of the observed overall mortality., Conclusions: High perforin-positive cardiac cell infiltration and male sex are independent adverse predictors of long-term mortality in CMi. Furthermore, exact quantification of immunohistochemically detected infiltrates is necessary to assess the prognosis., (© 2017 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.)
- Published
- 2017
- Full Text
- View/download PDF
18. Immunosuppressive treatment in fulminant myocarditis and gene expression pattern associated with, but no histological confirmation of giant cell myocarditis.
- Author
-
Fruhwald F, Lassner D, Fruhwald S, Gross UM, Dapunt O, and Schultheiss HP
- Abstract
A healthy woman with acute onset of pulmonary oedema and severely depressed left ventricular function underwent endomyocardial biopsy under the clinical suspicion of fulminant myocarditis. While awaiting the results of biopsy, the situation deteriorated to Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) and extracorporeal membrane oxygenation was implanted. Finally, immunohistochemistry in biopsy specimen corresponded to fulminant lymphocytic myocarditis, although active myocarditis was excluded. Furthermore, gene expression profiling identified giant cell myocarditis although multinuclear cells were absent. This prompted the start of immunosuppression with cortisone and cyclosporine. The patient fully recovered.
- Published
- 2017
- Full Text
- View/download PDF
19. High Prevalence of Infectious Adeno-associated Virus (AAV) in Human Peripheral Blood Mononuclear Cells Indicative of T Lymphocytes as Sites of AAV Persistence.
- Author
-
Hüser D, Khalid D, Lutter T, Hammer EM, Weger S, Heßler M, Kalus U, Tauchmann Y, Hensel-Wiegel K, Lassner D, and Heilbronn R
- Subjects
- DNA, Viral, Dependovirus classification, Humans, Immunocompromised Host, Leukocytes, Mononuclear immunology, Polymerase Chain Reaction, Prevalence, Seroepidemiologic Studies, T-Lymphocytes immunology, Virus Activation, Virus Latency, Dependovirus physiology, Leukocytes, Mononuclear virology, Parvoviridae Infections epidemiology, Parvoviridae Infections virology, T-Lymphocytes virology
- Abstract
Seroepidemiology shows that infections with adeno-associated virus (AAV) are widespread, but diverse AAV serotypes isolated from humans or nonhuman primates have so far not been proven to be causes of human disease. In view of the increasing success of AAV-derived vectors in human gene therapy, definition of the in vivo sites of wild-type AAV persistence and the clinical consequences of its reactivation is becoming increasingly urgent. Here, we identify the presumed cell type for AAV persistence in the human host by highly sensitive AAV PCRs developed for the full spectrum of human AAV serotypes. In genomic-DNA samples from leukocytes of 243 healthy blood donors, 34% were found to be AAV positive, predominantly AAV type 2 (AAV2) (77%), AAV5 (19%), and additional serotypes. Roughly 11% of the blood donors had mixed AAV infections. AAV prevalence was dramatically increased in immunosuppressed patients, 76% of whom were AAV positive. Of these, at least 45% displayed mixed infections. Follow-up of single blood donors over 2 years allowed repeated detection of the initial and/or additional AAV serotypes, suggestive of fluctuating, persistent infection. Leukocyte separation revealed that AAV resided in CD3
+ T lymphocytes, perceived as the putative in vivo site of AAV persistence. Moreover, infectious AAVs of various serotypes could be rescued and propagated from numerous samples. The high prevalence and broad spectrum of human AAVs in leukocytes closely follow AAV seroepidemiology. Immunosuppression obviously enhances AAV replication in parallel with activation of human cytomegalovirus (HCMV) and human herpesvirus 6 (HHV-6), reminiscent of herpesvirus-induced AAV activation., Importance: Adeno-associated virus is viewed as apathogenic and replication defective, requiring coinfection with adenovirus or herpesvirus for productive infection. In vivo persistence of a defective virus requires latency in specialized cell types to escape the host immune response until viral spread becomes possible. Reactivation from latency can be induced by diverse stimuli, including infections, typically induced upon host immunosuppression. We show for the first time that infectious AAV is highly prevalent in human leukocytes, specifically T lymphocytes, and that AAV is strongly amplified upon immunosuppression, along with reactivation of latent human herpesviruses. In the absence of an animal model to study the AAV life cycle, our findings in the human host will advance the understanding of AAV latency, reactivation, and in vivo pathogenesis., (Copyright © 2017 American Society for Microbiology.)- Published
- 2017
- Full Text
- View/download PDF
20. Absent MicroRNAs in Different Tissues of Patients with Acquired Cardiomyopathy.
- Author
-
Siegismund CS, Rohde M, Kühl U, Escher F, Schultheiss HP, and Lassner D
- Subjects
- Algorithms, Cardiomyopathies diagnosis, Cardiomyopathies pathology, Cerebrospinal Fluid metabolism, Humans, Leukocytes, Mononuclear cytology, MicroRNAs blood, MicroRNAs isolation & purification, Nucleic Acid Amplification Techniques, Oligonucleotide Array Sequence Analysis, Cardiomyopathies genetics, MicroRNAs metabolism
- Abstract
MicroRNAs (miRNAs) can be found in a wide range of tissues and body fluids, and their specific signatures can be used to determine diseases or predict clinical courses. The miRNA profiles in biological samples (tissue, serum, peripheral blood mononuclear cells or other body fluids) differ significantly even in the same patient and therefore have their own specificity for the presented condition. Complex profiles of deregulated miRNAs are of high interest, whereas the importance of non-expressed miRNAs was ignored. Since miRNAs regulate gene expression rather negatively, absent miRNAs could indicate genes with unaltered expression that therefore are normally expressed in specific compartments or under specific disease situations. For the first time, non-detectable miRNAs in different tissues and body fluids from patients with different diseases (cardiomyopathies, Alzheimer's disease, bladder cancer, and ocular cancer) were analyzed and compared in this study. miRNA expression data were generated by microarray or TaqMan PCR-based platforms. Lists of absent miRNAs of primarily cardiac patients (myocardium, blood cells, and serum) were clustered and analyzed for potentially involved pathways using two prediction platforms, i.e., miRNA enrichment analysis and annotation tool (miEAA) and DIANA miRPath. Extensive search in biomedical publication databases for the relevance of non-expressed miRNAs in predicted pathways revealed no evidence for their involvement in heart-related pathways as indicated by software tools, confirming proposed approach., (Copyright © 2016 The Authors. Production and hosting by Elsevier Ltd.. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
21. Long noncoding RNA MALAT1-derived mascRNA is involved in cardiovascular innate immunity.
- Author
-
Gast M, Schroen B, Voigt A, Haas J, Kuehl U, Lassner D, Skurk C, Escher F, Wang X, Kratzer A, Michalik K, Papageorgiou A, Peters T, Loebel M, Wilk S, Althof N, Prasanth KV, Katus H, Meder B, Nakagawa S, Scheibenbogen C, Schultheiss HP, Landmesser U, Dimmeler S, Heymans S, and Poller W
- Subjects
- Humans, Cardiovascular System immunology, Cardiovascular System metabolism, Immunity, Innate genetics, RNA, Long Noncoding genetics, RNA, Long Noncoding metabolism
- Published
- 2016
- Full Text
- View/download PDF
22. Individuals with inherited chromosomally integrated human herpes virus 6 (ciHHV-6) have functionally active HHV-6 specific T-cell immunity.
- Author
-
Strenger V, Kayser S, Witte KE, Lassner D, Schwinger W, Jahn G, Urban C, and Feuchtinger T
- Subjects
- Adult, Aged, Aged, 80 and over, Chromosomes, Human, Female, Humans, Male, Middle Aged, Roseolovirus Infections genetics, Roseolovirus Infections immunology, T-Lymphocytes metabolism, Virus Integration, Young Adult, Cytokines metabolism, Herpesvirus 6, Human genetics, Roseolovirus Infections virology, T-Lymphocytes cytology
- Abstract
To evaluate the human herpes virus 6 (HHV-6) -specific immune response in individuals with chromosomally integrated HHV-6 (ciHHV-6), we measured HHV-6-antigen-specific cytokine responses (interferon-γ, interleukin-2, tumour necrosis factor-α) in T cells by flow cytometry in 12 and 16 individuals with and without ciHHV-6, respectively. All individuals with ciHHV-6 showed HHV-6-specific T cells with higher frequencies of HHV-6-specific CD8(+) cells (0.03-14.93, median 2.15% of CD8(+) cells) compared with non-ciHHV-6 (0.0-10.67, median 0.36%, p 0.026). The observed increased HHV-6-specific functionally active responses in individuals with ciHHV-6 clearly disprove speculations on immune tolerance in ciHHV-6 and indicate clinical and immunological implications of ciHHV-6., (Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
23. Complete Genome Sequence of Germline Chromosomally Integrated Human Herpesvirus 6A and Analyses Integration Sites Define a New Human Endogenous Virus with Potential to Reactivate as an Emerging Infection.
- Author
-
Tweedy J, Spyrou MA, Pearson M, Lassner D, Kuhl U, and Gompels UA
- Subjects
- Base Sequence, Chromosomes, Human genetics, Heart Failure genetics, Herpesvirus 6, Human genetics, Humans, Molecular Sequence Data, Phylogeny, Prospective Studies, Roseolovirus Infections genetics, Chromosomes, Human virology, Heart Failure virology, Herpesvirus 6, Human physiology, Roseolovirus Infections virology, Virus Integration
- Abstract
Human herpesvirus-6A and B (HHV-6A, HHV-6B) have recently defined endogenous genomes, resulting from integration into the germline: chromosomally-integrated "CiHHV-6A/B". These affect approximately 1.0% of human populations, giving potential for virus gene expression in every cell. We previously showed that CiHHV-6A was more divergent than CiHHV-6B by examining four genes in 44 European CiHHV-6A/B cardiac/haematology patients. There was evidence for gene expression/reactivation, implying functional non-defective genomes. To further define the relationship between HHV-6A and CiHHV-6A we used next-generation sequencing to characterize genomes from three CiHHV-6A cardiac patients. Comparisons to known exogenous HHV-6A showed CiHHV-6A genomes formed a separate clade; including all 85 non-interrupted genes and necessary cis-acting signals for reactivation as infectious virus. Greater single nucleotide polymorphism (SNP) density was defined in 16 genes and the direct repeats (DR) terminal regions. Using these SNPs, deep sequencing analyses demonstrated superinfection with exogenous HHV-6A in two of the CiHHV-6A patients with recurrent cardiac disease. Characterisation of the integration sites in twelve patients identified the human chromosome 17p subtelomere as a prevalent site, which had specific repeat structures and phylogenetically related CiHHV-6A coding sequences indicating common ancestral origins. Overall CiHHV-6A genomes were similar, but distinct from known exogenous HHV-6A virus, and have the capacity to reactivate as emerging virus infections.
- Published
- 2016
- Full Text
- View/download PDF
24. MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease.
- Author
-
Denk J, Boelmans K, Siegismund C, Lassner D, Arlt S, and Jahn H
- Subjects
- Aged, Alzheimer Disease cerebrospinal fluid, Alzheimer Disease pathology, Amyloid Precursor Protein Secretases cerebrospinal fluid, Amyloid Precursor Protein Secretases genetics, Aspartic Acid Endopeptidases cerebrospinal fluid, Aspartic Acid Endopeptidases genetics, Biomarkers cerebrospinal fluid, Discriminant Analysis, Female, Gene Expression Profiling, Humans, Male, MicroRNAs cerebrospinal fluid, Middle Aged, Oligonucleotide Array Sequence Analysis, Signal Transduction, TOR Serine-Threonine Kinases cerebrospinal fluid, TOR Serine-Threonine Kinases genetics, tau Proteins cerebrospinal fluid, tau Proteins genetics, Alzheimer Disease diagnosis, Alzheimer Disease genetics, Epigenesis, Genetic, MicroRNAs genetics
- Abstract
The miRBase-21 database currently lists 1881 microRNA (miRNA) precursors and 2585 unique mature human miRNAs. Since their discovery, miRNAs have proved to present a new level of epigenetic post-transcriptional control of protein synthesis. Initial results point to a possible involvement of miRNA in Alzheimer's disease (AD). We applied OpenArray technology to profile the expression of 1178 unique miRNAs in cerebrospinal fluid (CSF) samples of AD patients (n = 22) and controls (n = 28). Using a Cq of 34 as cut-off, we identified positive signals for 441 miRNAs, while 729 miRNAs could not be detected, indicating that at least 37% of miRNAs are present in the brain. We found 74 miRNAs being down- and 74 miRNAs being up-regulated in AD using a 1.5 fold change threshold. By applying the new explorative "Measure of relevance" method, 6 reliable and 9 informative biomarkers were identified. Confirmatory MANCOVA revealed reliable miR-100, miR-146a and miR-1274a as differentially expressed in AD reaching Bonferroni corrected significance. MANCOVA also confirmed differential expression of informative miR-103, miR-375, miR-505#, miR-708, miR-4467, miR-219, miR-296, miR-766 and miR-3622b-3p. Discrimination analysis using a combination of miR-100, miR-103 and miR-375 was able to detect AD in CSF by positively classifying controls and AD cases with 96.4% and 95.5% accuracy, respectively. Referring to the Ingenuity database we could identify a set of AD associated genes that are targeted by these miRNAs. Highly predicted targets included genes involved in the regulation of tau and amyloid pathways in AD like MAPT, BACE1 and mTOR.
- Published
- 2015
- Full Text
- View/download PDF
25. Differential Cardiac MicroRNA Expression Predicts the Clinical Course in Human Enterovirus Cardiomyopathy.
- Author
-
Kuehl U, Lassner D, Gast M, Stroux A, Rohde M, Siegismund C, Wang X, Escher F, Gross M, Skurk C, Tschoepe C, Loebel M, Scheibenbogen C, Schultheiss HP, and Poller W
- Subjects
- Adult, Area Under Curve, Cardiomyopathies diagnosis, Cardiomyopathies immunology, Cardiomyopathies virology, Cell Line, Tumor, Coxsackievirus Infections diagnosis, Coxsackievirus Infections immunology, Coxsackievirus Infections virology, Disease Progression, Enterovirus B, Human immunology, Female, Gene Expression Regulation, Gene Knockdown Techniques, Genetic Markers, Host-Pathogen Interactions, Humans, Male, MicroRNAs metabolism, Middle Aged, Multivariate Analysis, Oligonucleotide Array Sequence Analysis, Oligonucleotides, Antisense genetics, Oligonucleotides, Antisense metabolism, Predictive Value of Tests, RNA, Messenger genetics, RNA, Messenger metabolism, ROC Curve, Reproducibility of Results, Transcriptome, Transfection, Cardiomyopathies genetics, Coxsackievirus Infections genetics, Enterovirus B, Human pathogenicity, Gene Expression Profiling methods, MicroRNAs genetics, Myocardium metabolism
- Abstract
Background: Investigation of disease pathogenesis confined to protein-coding regions of the genome may be incomplete because many noncoding variants are associated with disease. We aimed to identify novel predictive markers for the course of enterovirus (CVB3) cardiomyopathy by screening for noncoding elements influencing the grossly different antiviral capacity of individual patients., Methods and Results: Transcriptome mapping of CVB3 cardiomyopathy patients revealed distinctive cardiac microRNA (miR) patterns associated with spontaneous virus clearance and recovery (CVB3-ELIM) versus virus persistence and progressive clinical deterioration (CVB3-PERS). Profiling of protein-coding genes and 754 miRs in endomyocardial biopsies of test cohorts was performed at their initial presentation, and those spontaneously eliminating the virus were compared with those with virus persistence on follow-up. miR profiling revealed highly significant differences in cardiac levels of 16 miRs, but not of protein-coding genes. Evaluation of this primary distinctive miR pattern in validation cohorts, and multivariate receiver operating characteristic curve analysis, confirmed this pattern as highly predictive for disease course (area under the curve, 0.897±0.071; 95% confidence interval, 0.758-1.000). Eight miRs were strongly induced in CVB3-PERS (miRs 135b, 155, 190, 422a, 489, 590, 601, 1290), but undetectable in CVB3-ELIM or controls. They are predicted to target multiple immune response genes, and 2 of these were confirmed by antisense-mediated ablation of miRs 135b, 190, and 422a in the monocytic THP-1 cell line., Conclusions: An immediate clinical application of the data is cardiac miR profiling to assess the risk of virus persistence and progressive clinical deterioration in CVB3 cardiomyopathy. Patients at risk are eligible for immediate antiviral therapy to minimize irreversible cardiac damage., (© 2015 American Heart Association, Inc.)
- Published
- 2015
- Full Text
- View/download PDF
26. Analyses of germline, chromosomally integrated human herpesvirus 6A and B genomes indicate emergent infection and new inflammatory mediators.
- Author
-
Tweedy J, Spyrou MA, Hubacek P, Kuhl U, Lassner D, and Gompels UA
- Subjects
- Cohort Studies, Cytokines analysis, Czech Republic, Germany, Humans, Infant, Molecular Sequence Data, Sequence Analysis, DNA, Viral Proteins analysis, Virus Activation, Chromosomes, Human virology, Germ Cells virology, Herpesvirus 6, Human genetics, Roseolovirus Infections virology
- Abstract
Human herpesvirus-6A (HHV-6A) is rarer than HHV-6B in many infant populations. However, they are similarly prevalent as germline, chromosomally integrated genomes (ciHHV-6A/B). This integrated form affects 0.1-1 % of the human population, where potentially virus gene expression could be in every cell, although virus relationships and health effects are not clear. In a Czech/German patient cohort ciHHV-6A was more common and diverse than ciHHV-6B. Quantitative PCR, nucleotide sequencing and telomeric integration site amplification characterized ciHHV-6 in 44 German myocarditis/cardiomyopathy and Czech malignancy/inflammatory disease (MI) patients plus donors. Comparisons were made to sequences from global virus reference strains, and blood DNA from childhood-infections from Zambia (HHV-6A mainly) and Japan (HHV-6B). The MI cohort were 86 % (18/21) ciHHV-6A, the cardiac cohort 65 % (13/20) ciHHV-6B, suggesting different disease links. Reactivation was supported by findings of 1) recombination between ciHHV-6A and HHV-6B genes in 20 % (4/21) of the MI cohort; 2) expression in a patient subset, of early/late transcripts from the inflammatory mediator genes chemokine receptor U51 and chemokine U83, both identical to ciHHV-6A DNA sequences; and 3) superinfection shown by deep sequencing identifying minor virus-variants only in ciHHV-6A, which expressed transcripts, indicating virus infection reactivates latent ciHHV-6A. Half the MI cohort had more than two copies per cell, median 5.2, indicative of reactivation. Remarkably, the integrated genomes encoded the secreted-active form of virus chemokines, rare in virus from childhood-infections. This shows integrated virus genomes can contribute new human genes with links to inflammatory pathology and supports ciHHV-6A reactivation as a source for emergent infection., (© 2015 The Authors.)
- Published
- 2015
- Full Text
- View/download PDF
27. Chromosomally integrated human herpesvirus 6 in heart failure: prevalence and treatment.
- Author
-
Kühl U, Lassner D, Wallaschek N, Gross UM, Krueger GR, Seeberg B, Kaufer BB, Escher F, Poller W, and Schultheiss HP
- Subjects
- Adult, Antiviral Agents therapeutic use, Cardiomyopathy, Dilated epidemiology, Cardiomyopathy, Dilated virology, Cohort Studies, Female, Ganciclovir therapeutic use, Germany epidemiology, Heart Failure virology, Humans, Male, Microscopy, Electron, Middle Aged, Myocarditis epidemiology, Myocarditis virology, Myocardium ultrastructure, Prevalence, Prospective Studies, Reverse Transcriptase Polymerase Chain Reaction, Roseolovirus Infections drug therapy, Treatment Outcome, Viral Load, DNA, Viral genetics, Heart virology, Heart Failure epidemiology, Herpesvirus 6, Human genetics, Myocardium metabolism, Roseolovirus Infections epidemiology, Virus Integration
- Abstract
Aims: Human herpesvirus 6 (HHV-6) A and B are two betaherpesviruses that are associated with many conditions including roseola, drug-induced hypersensitivity syndrome, limbic encephalitis, and myocarditis. HHV-6 is integrated in the germline [chromosomically integrated HHV-6 (ciHHV-6)] in ∼0.8% of the human population. To date, the prevalence, species distribution, and treatment responses of ciHHV-6 are unknown for cardiac patients., Methods and Results: We determined the prevalence of HHV-6 and ciHHV-6 genotypes in 1656 endomyocardial biopsies of patients with persisting unexplained symptoms of heart failure. Infection of cardiac tissue was identified by nested PCR, electron microscopy, and immunohistochemistry. Virus load and mRNA levels were followed in ciHHV-6 patients treated with ganciclovir. HHV-6 was detected in 273 of 1656 cardiac tissues (16.5%; HHV-6B, 98.2%, HHV-6A, 1.8%) by PCR. Nineteen of the 1656 patients (1.1%) presented with persistently high HHV-6 copy numbers indicative of ciHHV-6. Sequencing confirmed ciHHV-6A in seven patients (36.8%) which was considerably higher than detected in non-ciHHV-6 patients. Inheritance was demonstrated in three selected families, confirming ciHHV-6 chromosomal integration by PCR and fluorescence in situ hybridization. HHV-6 reactivation and chromosomal integration were confirmed in peripheral blood mononuclear cells and heart tissue. Virus particles were identified in degenerating myocytes and interstitial cells. Antiviral treatment abolished viral mRNA and ameliorated cardiac symptoms., Conclusion: Virus replication in cardiac tissue of ciHHV-6 heart failure patients suggests that ciHHV-6 reactivation causes persistence of unexplained heart failure symptoms. We demonstrated that antiviral treatment, effective in decreasing viral transcripts and clinical complaints of cardiomyopathies, is a new therapeutic option for ciHHV-6-associated diseases., (© 2014 The Authors. European Journal of Heart Failure © 2014 European Society of Cardiology.)
- Published
- 2015
- Full Text
- View/download PDF
28. Presence of perforin in endomyocardial biopsies of patients with inflammatory cardiomyopathy predicts poor outcome.
- Author
-
Escher F, Kühl U, Lassner D, Stroux A, Westermann D, Skurk C, Tschöpe C, Poller W, and Schultheiss HP
- Subjects
- Adult, Aged, Biopsy, Female, Hemodynamics, Humans, Inflammation metabolism, Inflammation pathology, Male, Middle Aged, Predictive Value of Tests, Prognosis, Ventricular Dysfunction, Left diagnosis, Ventricular Dysfunction, Left etiology, Ventricular Dysfunction, Left physiopathology, Cardiomyopathies diagnosis, Cardiomyopathies metabolism, Cardiomyopathies pathology, Cardiomyopathies physiopathology, Myocardium metabolism, Myocardium pathology, Perforin analysis, Perforin metabolism
- Abstract
Aims: Intramyocardial inflammation is considered an adverse prognostic factor in inflammatory cardiomyopathy (CMi). However, the precise nature of immune system factors relevant for the prediction of long-term course remains elusive. The aim of this study was to analyse the prognostic relevance of perforin in a large cohort of patients with CMi., Methods and Results: We investigated 495 consecutive patients with suspected CMi, undergoing endomyocardial biopsies (EMBs), and examined haemodynamic measurements after a long follow-up period (interquartile range 10.2-37.1 months). In EMBs, myocardial inflammation was assessed by histology and immunohistology. At follow-up, 388 patients (Group I) showed stable mild dysfunction or significant improvement, with LVEF rising from 46.2 ± 14.8% to 64.3 ± 12.3% (P < 0.0001). Lack of improvement of LV function or significant deterioration of LVEF from 42.1 ± 14.2% to 32.3 ± 11.6% (P < 0.0001) was observed in 107 patients (Group II). Multivariable statistical analysis of LVEF and immunohistochemical parameters in all patients revealed that the single most important predictor of LVEF development was detection of perforin in EMBs, with an odds ratio (OR) of 7.922 [95% confidence interval (CI) 4.380-14.326; P < 0.001] for deteriorating LVEF. Importantly, baseline LVEF (OR 0.962), LV end-diastolic diameter (OR 1.847), and other immmunohistochemical parameters (CD3, Mac-1, CD45R0, LFA-1, HLA-1, and ICAM-1) made minor or insignificant contributions to LVEF course in these 495 patients., Conclusions: In this EMB-based analysis of the long-term course of CMi we identified, for the first time, that detection of perforin in the myocardium is a key predictor of LVEF course., (© 2014 The Authors. European Journal of Heart Failure © 2014 European Society of Cardiology.)
- Published
- 2014
- Full Text
- View/download PDF
29. Improved diagnosis of idiopathic giant cell myocarditis and cardiac sarcoidosis by myocardial gene expression profiling.
- Author
-
Lassner D, Kühl U, Siegismund CS, Rohde M, Elezkurtaj S, Escher F, Tschöpe C, Gross UM, Poller W, and Schultheiss HP
- Subjects
- DNA, Complementary metabolism, Female, Humans, Immunohistochemistry, Male, Middle Aged, Myocarditis diagnosis, Retrospective Studies, Cardiomyopathies diagnosis, Gene Expression Profiling methods, Sarcoidosis diagnosis
- Abstract
Aims: Improvement of clinical diagnostics of idiopathic giant cell myocarditis (IGCM) and cardiac sarcoidosis (CS), two frequently fatal human myocardial diseases. Currently, IGCM and CS are diagnosed based on differential patterns of inflammatory cell infiltration and non-caseating granulomas in histological sections of endomyocardial biopsies (EMBs), after heart explantation or postmortem. We report on a method for improved differential diagnosis by myocardial gene expression profiling in EMBs., Methods and Results: We examined gene expression profiles in EMBs from 10 patients with histopathologically proven IGCM, 10 with CS, 18 with active myocarditis (MCA), and 80 inflammation-free control subjects by quantitative RT-QPCR. We identified distinct differential profiles that allowed a clear discrimination of tissues harbouring giant cells (IGCS, CS) from those with MCA or inflammation-free controls. The expression levels of genes coding for cytokines or chemokines (CCL20, IFNB1, IL6, IL17D; P < 0.05), cellular receptors (ADIPOR2, CCR5, CCR6, TLR4, TLR8; P < 0.05), and proteins involved in the mitochondrial energy metabolism (CPT1, CYB, DHODH; P < 0.05) were deregulated in 2- to 300-fold, respectively. Bioinformatic analyses and correlation of the gene expression data with immunohistochemical findings provided novel information regarding the differential cellular and molecular pathomechanisms in IGCM, CS, and MCA., Conclusion: Myocardial gene expression profiling is a reliable method to predict the presence of multinuclear giant cells in the myocardium, even without a direct histological proof, in single small EMB sections, and thus to reduce the risk of sampling errors. This profiling also facilitates the discrimination between IGCM and CS, as two different clinical entities that require immediate and tailored differential therapy., (Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2014. For permissions please email: journals.permissions@oup.com.)
- Published
- 2014
- Full Text
- View/download PDF
30. High leptin and resistin expression in chronic heart failure: adverse outcome in patients with dilated and inflammatory cardiomyopathy.
- Author
-
Bobbert P, Jenke A, Bobbert T, Kühl U, Rauch U, Lassner D, Scheibenbogen C, Poller W, Schultheiss HP, and Skurk C
- Subjects
- Adult, Biomarkers, Cardiomyopathies epidemiology, Disease Progression, Female, Health Status Indicators, Heart Failure epidemiology, Heart Failure pathology, Hemodynamics, Humans, Inflammation pathology, Leptin blood, Male, Middle Aged, Multivariate Analysis, Prognosis, ROC Curve, Resistin blood, Statistics as Topic, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left, Cardiomyopathies drug therapy, Heart Failure drug therapy, Inflammation blood, Leptin biosynthesis, Resistin biosynthesis
- Abstract
Aim: The expression of leptin and resistin is known to be positively correlated with the incidence of chronic heart failure (CHF). Both adipokines have been implicated in immunomodulation and cardiac remodelling. Therefore, we performed for the first time a clinical study to elucidate the effects of leptin and resistin on progression of CHF in patients with non-ischaemic dilated (DCM) and inflammatory (DCMi) cardiomyopathy., Methods and Results: For the clinical study 120 patients were divided into a control (n = 16), DCM (n = 52), and DCMi (n = 52) group to determine the effect of leptin and resistin on CHF progression. Nuclear factor-κB (NF-κB) activation, reactive oxygen species generation, and tumour necrosis factor-α (TNF-α) and interleukin-6 (IL-6) expression following adipokine exposition were determined in vitro in cardiomyocytes. Leptin and resistin systemic plasma levels and not cardiac expression were significantly elevated in patients with DCM (leptin, 13.12 ± 17.2 ng/mL, P < 0.05; resistin, 6.87 ± 2.25 ng/mL, P < 0.05) and DCMi (leptin, 13.63 ± 16 ng/mL, P < 0.05; resistin, 7.27 ± 2.2 ng/mL, P < 0.05) compared with the control group (leptin, 7.34 ± 5.7 ng/mL; resistin, 4.4 ± 1.18 ng/mL). A multivariate linear regression model revealed low leptin and resistin plasma levels as contributors for favourable cardiac functional parameters at 6-month follow-up independent of inflammatory conditions. Cell culture experiments in vitro showed leptin and resistin to be potent regulators of TNF-α and IL-6 expression in cardiomyocytes, leading to significantly increased redox stress in cardiac cells., Conclusions: High leptin and resistin expression in patients with DCM and DCMi is associated with CHF progression, i.e. severe cardiac dysfunction, independent of immune responses.
- Published
- 2012
- Full Text
- View/download PDF
31. Interferon-Beta improves survival in enterovirus-associated cardiomyopathy.
- Author
-
Kühl U, Lassner D, von Schlippenbach J, Poller W, and Schultheiss HP
- Subjects
- Adult, Antiviral Agents blood, Biopsy, Cardiomyopathy, Dilated mortality, Cardiomyopathy, Dilated virology, Cohort Studies, Enterovirus Infections mortality, Enterovirus Infections virology, Female, Follow-Up Studies, Humans, Interferon-beta blood, Male, Middle Aged, Treatment Outcome, Antiviral Agents administration & dosage, Cardiomyopathy, Dilated drug therapy, Enterovirus isolation & purification, Enterovirus Infections drug therapy, Interferon-beta administration & dosage
- Published
- 2012
- Full Text
- View/download PDF
32. The mitochondrial respiratory chain has a critical role in the antiviral process in Coxsackievirus B3-induced myocarditis.
- Author
-
Ebermann L, Wika S, Klumpe I, Hammer E, Klingel K, Lassner D, Völker U, Erben U, Zeichhardt H, Schultheiss HP, and Dörner A
- Subjects
- Animals, Apoptosis, Disease Resistance, Electron Transport Complex I physiology, Heart virology, Male, Mice, Mice, Inbred C57BL, Oxidative Stress, Viral Load, Coxsackievirus Infections immunology, Electron Transport physiology, Enterovirus B, Human, Mitochondria, Heart physiology, Myocarditis immunology
- Abstract
Well-established differences in Coxsackievirus B3 (CVB3) elimination in resistant C57BL/6 and permissive A.SW/SnJ mice provide suitable models for studying the significance of the link between mitochondrial respiratory chain (RC), antioxidative stress components and mitochondrion-related apoptosis in the context of myocardial virus elimination. Distinct myocardial CVB3 titer in C57BL/6 (2.5 ± 1.4 × 10(4) plaque-forming units (p.f.u.)/g tissue) and A.SW/SnJ mice (1.4 ± 0.8 × 10(7) p.f.u./g) were associated with differences in the cardiac mitochondrial function 8 days post infection (p.i.). Infected C57BL/6 mouse hearts disclosed increased complex I (CI) and CIII activity, but restricted CII and normal CIV activity of RC. Reduced expression of the antioxidative catalase was accompanied by elevated lipid peroxidation (LPO), indicating oxidative stress. Intrinsic apoptosis was activated demonstrated by elevated levels of Bax, Bcl-2, caspase 3 and DNA degradation. In contrast, all myocardial RC complex activities were restricted in CVB3-infected A.SW/SnJ mice. The antioxidative system provided sufficient protection against oxidative stress shown by an elevated catalase expression and unaltered LPO. Bax and Bcl-2 levels were unchanged in CVB3-infected A.SW/SnJ mice, while caspase 3 was moderately increased but no DNA degradation was detectable. Correlation analyses including data from the two mouse strains revealed that reduced CVB3 titer correlated with increased CI and CIII activity, oxidative stress as well as active apoptosis during acute myocarditis (MC). C57BL/6 mice completely eliminated CVB3 and inflammation and normalized all intracellular parameters, while A.SW/SnJ mice showed permanently restricted CI activity in chronic MC 90 days p.i., at which time the replicating virus was no longer detectable but immunological processes were still active. Consequently, the regulation of energy metabolism appears crucial for an effective virus elimination and may be of prognostic and therapeutic significance for patients with virus-induced MC.
- Published
- 2012
- Full Text
- View/download PDF
33. Expression of functional T-cell markers and T-cell receptor Vbeta repertoire in endomyocardial biopsies from patients presenting with acute myocarditis and dilated cardiomyopathy.
- Author
-
Noutsias M, Rohde M, Göldner K, Block A, Blunert K, Hemaidan L, Hummel M, Blohm JH, Lassner D, Kühl U, Schultheiss HP, Volk HD, and Kotsch K
- Subjects
- Acute Disease, Adult, Aged, Biopsy, Cardiomyopathy, Dilated virology, Endocardium pathology, Female, Gene Expression, Humans, Male, Middle Aged, Myocarditis virology, Myocardium pathology, Receptors, Antigen, T-Cell, alpha-beta genetics, Retrospective Studies, Reverse Transcriptase Polymerase Chain Reaction, Biomarkers metabolism, Cardiomyopathy, Dilated immunology, Myocarditis immunology, Receptors, Antigen, T-Cell, alpha-beta metabolism, T-Lymphocytes metabolism
- Abstract
Aims: To quantify and functionally characterize the intramyocardial T-cells in endomyocardial biopsies (EMBs) from patients presenting with acute myocarditis (AMC) and dilated cardiomyopathy (DCM)., Methods and Results: Expression of genes characterizing Th1 [interferon (IFN)γ, Tbet-1, Eomesodermin, interleukin (IL)-27], Th2 (IL-4, IL-5, GATA3), Th17 (IL-17), regulatory [regulatory T-cells (Treg); FoxP3, TGFβ, IL-10], anergic (GRAIL), and cytotoxic T-cells (CTLs: Perforin, Granulysin, Granzyme A), as well as of functional T-cell receptor Vbeta (TRBV) families were investigated in EMBs from AMC patients (n= 58) and DCM patients (n= 34) by pre-amplified real-time reverse transcription-polymerase chain reaction. These data were compared with EMBs from n= 19 controls. Expression of CD3d, CD3z, and TRBC (T-cell receptor beta constant region) were associated with the immunohistological diagnosis of inflammatory cardiomyopathy (DCMi). In EMBs from DCM patients with increased CD3d expression, significantly increased markers of Th1 (IFNγ, T-bet, Eomesodermin), regulatory T-cells (Treg; FoxP3, TGFβ), and cytotoxic T-cells (CTLs: Perforin, Granulysin, Granzyme A) were present, while no differential polarization of T-cells was found in EMBs form AMC patients. A differential dominance of distinct functional TRBV families was associated with different cardiotropic viruses: TRBV 11 and 24 with Parvovirus B19; TRBV4, 10 and 28 with human herpes virus type 6; and TRBV14 for Coxsackie virus, respectively., Conclusions: The T-cell infiltrates in human DCMi are characterized by differential expression of functional T-cell markers indicating Th1, Treg, and CTLs, while no major role could be confirmed for Th17. The virus-associated differential TRBV dominance suggests an antiviral specificity of virus-induced T-cell responses in human DCMi.
- Published
- 2011
- Full Text
- View/download PDF
34. Transactivation of human parvovirus B19 gene expression in endothelial cells by adenoviral helper functions.
- Author
-
Pozzuto T, von Kietzell K, Bock T, Schmidt-Lucke C, Poller W, Zobel T, Lassner D, Zeichhardt H, Weger S, and Fechner H
- Subjects
- Adenovirus E1A Proteins metabolism, Adenovirus E4 Proteins metabolism, Cells, Cultured, Humans, Parvovirus B19, Human genetics, Transcription, Genetic, Adenoviruses, Human genetics, Endothelial Cells virology, Gene Expression Regulation, Viral, Parvovirus B19, Human physiology, Trans-Activators metabolism, Transcriptional Activation, Viral Proteins metabolism
- Abstract
Human parvovirus B19 (B19V) DNA is highly prevalent in endothelial cells lining up intramyocardial arterioles and postcapillary venules of patients with chronic myocarditis and cardiomyopathies. We addressed the question of a possible stimulation of B19V gene expression in endothelial cells by infection with adenoviruses. Adenovirus infection led to a strong augmentation of B19V structural and nonstructural proteins in individual endothelial cells infected with B19V or transfected with an infectious B19V genome. Transactivation was mostly mediated at the level of transcription and not due to adenovirus-mediated induction of second-strand synthesis from the single-stranded parvoviral genome. The main adenoviral functions required were E1A and E4orf6, which displayed synergistic effects. Furthermore, a limited B19V genome replication could be demonstrated in endothelial cells and adenovirus infection induced the appearance of putative dimeric replication intermediates. Thus the almost complete block in B19V gene expression seen in endothelial cells can be abrogated by infection with other viruses., (Copyright © 2010 Elsevier Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
35. Cardiac phenotype and angiotensin II levels in AT1a, AT1b, and AT2 receptor single, double, and triple knockouts.
- Author
-
van Esch JH, Gembardt F, Sterner-Kock A, Heringer-Walther S, Le TH, Lassner D, Stijnen T, Coffman TM, Schultheiss HP, Danser AH, and Walther T
- Subjects
- Angiotensin II administration & dosage, Angiotensin II blood, Animals, Atrophy, Coronary Circulation, Fibrosis, Genotype, Kidney metabolism, Male, Mice, Mice, Knockout, Myocardium pathology, Natriuretic Peptide, Brain metabolism, Perfusion, Phenotype, Receptor, Angiotensin, Type 1 genetics, Receptor, Angiotensin, Type 2 genetics, Ventricular Function, Left, Ventricular Pressure, Ventricular Remodeling, Angiotensin II metabolism, Myocardium metabolism, Receptor, Angiotensin, Type 1 deficiency, Receptor, Angiotensin, Type 2 deficiency
- Abstract
Aims: Our aim was to determine the contribution of the three angiotensin (Ang) II receptor subtypes (AT(1a), AT(1b), AT(2)) to coronary responsiveness, cardiac histopathology, and tissue Ang II levels using mice deficient for one, two, or all three Ang II receptors., Methods and Results: Hearts of knockout mice and their wild-type controls were collected for histochemistry or perfused according to Langendorff, and kidneys were removed to measure tissue Ang II. Ang II dose-dependently decreased coronary flow (CF) and left ventricular systolic pressure (LVSP), and these effects were absent in all genotypes deficient for AT(1a), independently of AT(1b) and AT(2). The deletion of Ang II receptors had an effect neither on the morphology of medium-sized vessels in the heart nor on the development of fibrosis. However, the lack of both AT(1) subtypes was associated with atrophic changes in the myocardium, a reduced CF and a reduced LVSP. AT(1a) deletion alone, independently of the presence or absence of AT(1b) and/or AT(2), reduced renal Ang II by 50% despite a five-fold rise of plasma Ang II. AT(1b) deletion, on top of AT(1a) deletion (but not alone), further decreased tissue Ang II, while increasing plasma Ang II. In mice deficient for all three Ang II receptors, renal Ang II was located only extracellularly., Conclusion: The lack of both AT(1) subtypes led to a baseline reduction of CF and LVSP, and the effects of Ang II on CF and LVSP were found to be exclusively mediated via AT(1a). The lack of AT(1a) or AT(1b) does not influence the development or maintenance of normal cardiac morphology, whereas deficiency for both receptors led to atrophic changes in the heart. Renal Ang II levels largely depend on AT(1) binding of extracellularly generated Ang II, and in the absence of all three Ang II receptors, renal Ang II is only located extracellularly.
- Published
- 2010
- Full Text
- View/download PDF
36. Parvovirus B19 profiles in patients presenting with acute myocarditis and chronic dilated cardiomyopathy.
- Author
-
Escher F, Modrow S, Sabi T, Kühl U, Lassner D, Schultheiss HP, and Noutsias M
- Subjects
- Acute Disease, Adult, Antibodies, Viral biosynthesis, Antibodies, Viral blood, Case-Control Studies, Chronic Disease, DNA, Viral blood, Female, Humans, Male, Middle Aged, Parvoviridae Infections complications, Parvovirus B19, Human immunology, Polymerase Chain Reaction, Prospective Studies, Cardiomyopathy, Dilated virology, Myocarditis virology, Parvoviridae Infections virology, Parvovirus B19, Human isolation & purification
- Abstract
Background: Parvovirus B19 (B19V) is the most prevalent cardiotropic virus in endomyocardial biopsies (EMBs) from patients presenting with acute myocarditis (AMC) and chronic dilated cardiomyopathy (DCM). We elucidated the role of B19V specific IgG and IgM antibodies against native VP2-capsids and denatured VP1-, VP2- and NS1-proteins, which discriminate disease acuity in other B19V related diseases, in patients presenting with clinically suspected AMC and DCM for the determination of the viral infection stage., Material/methods: n=62 prospectively enrolled AMC (n=33) and DCM (n=29) patients were investigated. B19V genomes were amplified in EMBs by nested PCR (nPCR). B19V-specific IgG and IgM were investigated by recomLine blots in the sera., Results: B19V genomes were detectable by nPCR with comparable frequencies in AMC (63.6%) and DCM patients (51.7%), respectively. IgM antibodies were detectable in 18.1% of the AMC, but not in DCM patients. In patients with myocardial B19V infection, antibody profiles indicating recent infections were more frequent in AMC (47.6%) compared with DCM patients (6.7%), while persistent/reactivating profiles were significantly more prevalent in DCM (20.0%) compared with AMC (0%) patients (p<0.05)., Conclusions: IgM B19V antibodies can be detected primarily in AMC, but not in DCM patients. The discrimination of the B19V specific IgG antibodies using recomLine blots may be suitable to distinguish acute versus chronic, and persistent/reactivating infection status in patients with myocardial B19V infection.
- Published
- 2008
37. NS1 specific CD8+ T-cells with effector function and TRBV11 dominance in a patient with parvovirus B19 associated inflammatory cardiomyopathy.
- Author
-
Streitz M, Noutsias M, Volkmer R, Rohde M, Brestrich G, Block A, Klippert K, Kotsch K, Ay B, Hummel M, Kühl U, Lassner D, Schultheiss HP, Volk HD, and Kern F
- Subjects
- Adult, Amino Acid Sequence, Base Sequence, DNA Primers, Flow Cytometry, Humans, Male, Reverse Transcriptase Polymerase Chain Reaction, CD8-Positive T-Lymphocytes immunology, Cardiomyopathies virology, Parvovirus B19, Human pathogenicity, Receptors, Antigen, T-Cell, alpha-beta immunology, Viral Nonstructural Proteins immunology
- Abstract
Background: Parvovirus B19 (B19V) is the most commonly detected virus in endomyocardial biopsies (EMBs) from patients with inflammatory cardiomyopathy (DCMi). Despite the importance of T-cells in antiviral defense, little is known about the role of B19V specific T-cells in this entity., Methodology and Principal Findings: An exceptionally high B19V viral load in EMBs (115,091 viral copies/mug nucleic acids), peripheral blood mononuclear cells (PBMCs) and serum was measured in a DCMi patient at initial presentation, suggesting B19V viremia. The B19V viral load in EMBs had decreased substantially 6 and 12 months afterwards, and was not traceable in PBMCs and the serum at these times. Using pools of overlapping peptides spanning the whole B19V proteome, strong CD8(+) T-cell responses were elicited to the 10-amino-acid peptides SALKLAIYKA (19.7% of all CD8(+) cells) and QSALKLAIYK (10%) and additional weaker responses to GLCPHCINVG (0.71%) and LLHTDFEQVM (0.06%). Real-time RT-PCR of IFNgamma secretion-assay-enriched T-cells responding to the peptides, SALKLAIYKA and GLCPHCINVG, revealed a disproportionately high T-cell receptor Vbeta (TRBV) 11 expression in this population. Furthermore, dominant expression of type-1 (IFNgamma, IL2, IL27 and T-bet) and of cytotoxic T-cell markers (Perforin and Granzyme B) was found, whereas gene expression indicating type-2 (IL4, GATA3) and regulatory T-cells (FoxP3) was low., Conclusions: Our results indicate that B19V Ag-specific CD8(+) T-cells with effector function are involved in B19V associated DCMi. In particular, a dominant role of TRBV11 and type-1/CTL effector cells in the T-cell mediated antiviral immune response is suggested. The persistence of B19V in the endomyocardium is a likely antigen source for the maintenance of CD8(+) T-cell responses to the identified epitopes.
- Published
- 2008
- Full Text
- View/download PDF
38. Immunohistological detection of Parvovirus B19 capsid proteins in endomyocardial biopsies from dilated cardiomyopathy patients.
- Author
-
Escher F, Kuhl U, Sabi T, Suckau L, Lassner D, Poller W, Schultheiss HP, and Noutsias M
- Subjects
- Adult, Antibodies, Viral immunology, Biopsy, Cell Line, Female, Fluorescent Antibody Technique, Genome, Viral genetics, Humans, Immunohistochemistry, Male, Parvovirus B19, Human genetics, Polymerase Chain Reaction, Transfection, Viral Load, Capsid Proteins immunology, Cardiomyopathy, Dilated pathology, Cardiomyopathy, Dilated virology, Endocardium pathology, Endocardium virology, Parvovirus B19, Human immunology
- Abstract
Background: Parvovirus B19 (B19V) has been identified as the most common virus in dilated cardiomyopathy (DCM) patients by PCR techniques. We investigated the detectability and the expression pattern of B19V proteins by immunohistology (IH) in endomyocardial biopsies (EMBs) from DCM patients, and its association with the standard proof of B19V genomes by nested PCR (nPCR., Material/methods: EMBs from 30 DCM patients were analyzed by nPCR for B19V genomes, and IH of B19V VP1/VP2 expression was carried out using the antibody clone R92F6. The specificity of this antibody was investigated on 293T cells transfected with pB19-M20. Positive anti-B19V IH staining (positive in n=14/46.6%) and nPCR proof of B19V genomes (positive in n=15/50%) were significantly associated (p=0.0003)., Results: Based on the B19V nPCR results, the sensitivity of anti-B19V-VP1/VP2 IH was 80.0%, and the specificity was 86.0%. B19V immunostaining was observed on interstitial cells in all IH positive cases, and was noted additionally on endothelial cells in 1, and on cardiomyocytes in 4 cases., Conclusions: IH detection of B19V VP1/VP2 expression provides a high association with the nPCR proof of B19V genomes in DCM patients. IH detection of B19V proteins enables a differentiation of B19V VP1/VP2 expressing cells within the myocardium.
- Published
- 2008
39. Images in cardiovascular medicine. Parvovirus-B19-associated active myocarditis with biventricular thrombi. Results of endomyocardial biopsy investigations and cardiac magnetic resonance imaging.
- Author
-
Noutsias M, Kuehl U, Lassner D, Gross U, Pauschinger M, Schultheiss HP, and Gutberlet M
- Subjects
- Adult, Anticoagulants therapeutic use, Biopsy, Cardiovascular Agents therapeutic use, Endocardium pathology, Heart Diseases drug therapy, Heart Diseases etiology, Heart Failure drug therapy, Heart Failure etiology, Humans, Male, Myocarditis pathology, Thrombosis drug therapy, Thrombosis etiology, Angina Pectoris etiology, Magnetic Resonance Imaging, Myocarditis etiology, Parvoviridae Infections complications, Parvovirus B19, Human
- Published
- 2007
- Full Text
- View/download PDF
40. Genomic expression profiling of human inflammatory cardiomyopathy (DCMi) suggests novel therapeutic targets.
- Author
-
Wittchen F, Suckau L, Witt H, Skurk C, Lassner D, Fechner H, Sipo I, Ungethüm U, Ruiz P, Pauschinger M, Tschope C, Rauch U, Kühl U, Schultheiss HP, and Poller W
- Subjects
- Adiponectin genetics, Adiponectin metabolism, Adult, Aged, Cysteine-Rich Protein 61, Cytokines pharmacology, Gene Expression Regulation drug effects, Gene Regulatory Networks, Humans, Immediate-Early Proteins genetics, Immediate-Early Proteins metabolism, Intercellular Signaling Peptides and Proteins genetics, Intercellular Signaling Peptides and Proteins metabolism, Middle Aged, Models, Biological, Myocytes, Cardiac drug effects, Myocytes, Cardiac metabolism, Cardiomyopathy, Dilated genetics, Cardiomyopathy, Dilated therapy, Gene Expression Profiling, Genome, Human genetics
- Abstract
The clinical phenotype of human dilated cardiomyopathy (DCM) encompasses a broad spectrum of etiologically distinct disorders. As targeting of etiology-related pathogenic pathways may be more efficient than current standard heart failure treatment, we obtained the genomic expression profile of a DCM subtype characterized by cardiac inflammation to identify possible new therapeutic targets in humans. In this inflammatory cardiomyopathy (DCMi), a distinctive cardiac expression pattern not described in any previous study of cardiac disorders was observed. Two significantly altered gene networks of particular interest and possible interdependence centered around the cysteine-rich angiogenic inducer 61 (CYR61) and adiponectin (APN) gene. CYR61 overexpression, as in human DCMi hearts in situ, was similarly induced by inflammatory cytokines in vascular endothelial cells in vitro. APN was strongly downregulated in DCMi hearts and completely abolished cytokine-dependent CYR61 induction in vitro. Dysbalance between the CYR61 and APN networks may play a pathogenic role in DCMi and contain novel therapeutic targets. Multiple immune cell-associated genes were also deregulated (e.g., chemokine ligand 14, interleukin-17D, nuclear factors of activated T cells). In contrast to previous investigations in patients with advanced or end-stage DCM where etiology-related pathomechanisms are overwhelmed by unspecific processes, the deregulations detected in this study occurred at a far less severe and most probably fully reversible disease stage.
- Published
- 2007
- Full Text
- View/download PDF
41. Viral persistence in the myocardium is associated with progressive cardiac dysfunction.
- Author
-
Kühl U, Pauschinger M, Seeberg B, Lassner D, Noutsias M, Poller W, and Schultheiss HP
- Subjects
- Adenoviridae isolation & purification, Adult, Enterovirus isolation & purification, Female, Follow-Up Studies, Heart virology, Hemodynamics, Herpesvirus 6, Human isolation & purification, Humans, Male, Middle Aged, Parvovirus B19, Human isolation & purification, Time Factors, Ventricular Dysfunction, Left pathology, Stroke Volume, Ventricular Dysfunction, Left physiopathology, Ventricular Dysfunction, Left virology, Virus Diseases complications
- Abstract
Background: Cardiotropic viral infections have been suspected as one possible cause of myocarditis and dilated cardiomyopathy. Although adverse outcomes in dilated cardiomyopathy patients have been documented, the natural course of heart diseases caused by cardiotropic viruses is unknown., Methods and Results: Consecutive patients (n=172) with biopsy-proven viral infection in endomyocardial biopsies (EMBs) were followed up by reanalysis of EMBs and hemodynamic measurements after a median period of 6.8 months (range, 5.4 to 11.9). Nested polymerase chain reaction (PCR) and reverse transcription-PCR were performed to analyze the genomic sequences. Myocardial inflammation was assessed by histology and immunohistology. At baseline, 32.6% of EMBs in the study group contained enteroviral (EV) RNA, 8.1% adenovirus (ADV) DNA, 36.6% parvovirus B19 (PVB19) DNA, and 10.5% human herpesvirus type 6 (HHV6) DNA. In 12.2% of the samples, dual infection with PVB19 and HHV6 was present. Follow-up analysis of EMBs by PCR documented spontaneous clearance of viral genomes in 36.2% (55/151) of all patients with single infections. Virus-specific clearance rates were 50% for EV, 35.7% for ADV, 22.2% for PVB19, and 44.4% for HHV6. In patients with dual infection with PVB19+ and HHV6(+)-, HHV6 was cleared in 42.8% (9/21), whereas PVB19 persisted in all 21 patients. Clearance of viral genomes was associated with a significant improvement in left ventricular ejection fraction (LVEF), improving from 50.2+/-19.1% to 58.1+/-15.9% (P<0.001). In contrast, LV function decreased in patients with persisting viral genomes (LVEF, 54.3+/-16.1% versus 51.4+/-16.1%, P<0.01)., Conclusions: In this first biopsy-based analysis of the course of viral heart disease, we show that EV, ADV, PVB19, and HHV6 persistence detected in the myocardium of patients with LV dysfunction was associated with a progressive impairment of LVEF, whereas spontaneous viral elimination was associated with a significant improvement in LV function.
- Published
- 2005
- Full Text
- View/download PDF
42. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction.
- Author
-
Kühl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, Poller W, Kandolf R, and Schultheiss HP
- Subjects
- Adult, Aged, Biopsy, Cardiomyopathy, Dilated etiology, Female, Humans, Inflammation, Male, Middle Aged, Myocarditis virology, Polymerase Chain Reaction, Prevalence, Ventricular Dysfunction, Left etiology, Virus Diseases physiopathology, Cardiomyopathy, Dilated virology, Genome, Viral, Heart virology, Ventricular Dysfunction, Left virology, Virus Diseases complications
- Abstract
Background: For a long time, enteroviruses have been considered to be the most common cause of acute viral myocarditis (MC), with possible transition from MC to dilated cardiomyopathy (DCM). Recent investigations have shown, however, that other viruses are also frequently encountered in MC patients, suggesting that persistence of various virus species may play a pathogenic role in the transition from MC to DCM. The purpose of this study was to screen endomyocardial biopsies (EMBs) from patients with "idiopathic" DCM for the presence of viral genomes by using polymerase chain reaction (PCR) to assess the frequency of cardiac viral infections that may be involved in the pathogenesis of the disease., Methods and Results: EMBs were obtained for PCR analysis from 245 consecutive patients (median left ventricular ejection fraction, 35.0%; range, 9% to 59%). PCR and reverse transcription-PCR were performed to detect the genomic sequences of enterovirus (EV), adenovirus (ADV), human cytomegalovirus (HCMV), herpes simplex virus, Epstein-Barr virus (EBV), human herpesvirus 6 (HHV-6), parvovirus B19 (PVB19), and influenza A and B viruses. Myocardial inflammation was assessed by histological and immunohistological analyses. Viral genomes could be amplified from EMBs of 165 (67.4%) of the 245 DCM patients: EV=23 (9.4%), ADV=4 (1.6%), PVB19=126 (51.4%), HHV-6=53 (21.6%), EBV=5 (2.0%), HCMV=2 (0.8%), including n=45 cases (27.3%) with multiple infections. Active or borderline myocarditis according to the Dallas classification did not exist in any case. Lymphocyte and macrophage infiltrates were not significantly different in virus-positive versus virus-negative patients., Conclusions: Viral genomes were frequently detected in EMBs of patients with systolic left ventricular dysfunction. Our data suggest that myocardial persistence of various viruses, often presenting as multiple infections, may play a role in the pathogenesis of DCM far more frequently than suspected so far.
- Published
- 2005
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.